magazine 29 Jul 2021

Download PDF Page flip version

Find out why the DIY and home renovation boom can continue and the companies which should benefit.

Shares examines the FTSE 100 investment trust you may not have heard of and discusses why same-delivery could be the latest phase in the grocery war.

Get the lowdown on forecast-busting numbers from the US tech titans, find out why keeping your Lifetime ISA in cash could be a mistake and discover why one investment bank reckons oil prices will hit $100 per barrel next year.

This week’s investment ideas include a chocolatier which is benefitting from a move online and there is an update on strong numbers from soft drinks giant Coca-Cola.

Apple, Alphabet, Microsoft beat forecasts but regulation threat lurks

Results suggest firms lack pricing power in key product areas

The S&P’s gains have been driven by a few heavyweight technology giants

Andy went from contracting to a permanent role and is now taking more control over his money

The two support service companies have a shared history

Three things the Franklin Templeton Emerging Markets Equity team are thinking about today

Technology could play a key role as the developing world emerges from the pandemic

Pent up demand should help sustain the surge in demand for DIY and do-it-for-me

App-based services aim to compete with the Big Four supermarkets

Inkjet technology group could be poised for a rapid rebound in profit

Wall Street billionaire Bill Ackman’s trust offers exposure to North America’s best businesses and is buying a stake in Universal Music

We explain how they work and why they differ to ordinary shares

Why investing in the markets through the tax efficient vehicle is likely to deliver better returns

Despite recent volatility big gains expected but what would it mean for markets?

Digital initiatives have enhanced the ability to attract customers and build the brand

Scope for considerable upside as the defence and protection firm moves past its recent problems

Its shares are up 30% since we said to buy in April    

With laboratories re-opening, opportunities will accelerate

Analysts continue to raise their forecasts after positive surprise

Company raises full year guidance after results beat forecasts

Our resident expert on why this approach won’t be for everyone